По вашему запросу найдено документов: 125

Страница 1 из 13

The role and mechanism of claudins in cancer
De-Wen, Wang, Wei-Han, Zhang, Galiullin, Danil (2022)
as possible diagnostic and treatment targets. Here, we discuss how claudin-related signaling pathways affect
SIGNALING PATHWAYS AND THERAPEUTIC APPROACHES IN GLIOBLASTOMA MULTIFORME (REVIEW)
KHABIBOV, M., GARIFULLIN, A., KHAMITOV, F., KHALIKOVA, L., BOUMBER, Y., KHADDOUR, K., FERNANDEZ, M., KUZNETSOVA, N., KIT, O., KHARIN, L. (2022)
in the pathogenesis of GBM, as well as therapies that target these pathways. Glioblastoma remains a diffi‑ cult
MicroRNAs as prognostic markers and therapeutic targets in gliomas
Sufianov, A., Begliarzade, S., Ilyasova, T., Liang, Y., Beylerli, O. (2022)
be used for diagnosis and prognosis, including the response of a particular patient to therapy
Prospects for the treatment of neurofibromatosis type 1: A review
Mustafin, R.N., Мустафин, Р.Н. (2022)
, it is necessary to develop an effective therapy for NF1. The effectiveness of complex therapy of NF1 with use
ВОЗМОЖНОСТИ КОМБИНИРОВАННОЙ ИММУНОТАРГЕТНОЙ ТЕРАПИИ МЕТАСТАТИЧЕСКОГО ПОЧЕЧНО-КЛЕТОЧНОГО РАКА. ОБЗОР ЛИТЕРАТУРЫ
POSSIBILITIES OF COMBINED IMMUNOTARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA. LITERATURE REVIEW
МЕНЬШИКОВ, К.В., СУЛТАНБАЕВ, А.В., МУСИН, Ш.И., РАХМАТУЛЛИНА, И.Р., МЕНЬШИКОВА, И.А., ХАММАТОВА, Л.А., ПОПОВА, Е.В., СУЛТАНБАЕВА, Н.И., ЛИПАТОВ, Д.О., MENSHIKOV, K.V., SULTANBAEV, A.V., MUSIN, SH.I., RAKHMATULLINA, I.R., MENSHIKOVA, I.A., KHAMMATOVA, L.A., POPOVA, E.V., SULTANBAEVA, N.I., LIPATOV, D.O. (2022)
POSSIBILITIES OF COMBINED IMMUNOTARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA. LITERATURE
Comparative analysis of immunosuppressive therapy effectiveness in COVID-19 patients
Tyurin, Anton V., Akhiyarova, Karina E., Valishin, Damir A., Sadretdinova, Lidiya D., Khusainova, Leonora N., Zagidullin, Naufal S., Gantseva, Khalida K., Pavlov, Valentin N. (2022)
The objective of our study was the analysis of using immunosuppressive therapy in patients
MicroRNAs as potential diagnostic markers of glial brain tumors
Sufianov, Albert, Begliarzade, Sema, Ilyasova, Tatiana, Xu, Xun, Beylerli, Ozal (2022)
. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogeneity and resistance to therapy. Modern
ПРОБЛЕМЫ И ДОСТИЖЕНИЯ В ИЗУЧЕНИИ КЛИНИКО-ГЕНЕТИЧЕСКИХ АСПЕКТОВ МУКОВИСЦИДОЗА
PROBLEMS AND ACHIEVEMENTS IN THE STUDY OF CLINICAL AND GENETIC ASPECTS OF CYSTIC FIBROSIS
АЮПОВА, Г.Р., МИННИАХМЕТОВ, И.Р., ХУСАИНОВА, Р.И., AYUPOVA, G.R., MINNIAKHMETOV, I.R., KHUSAINOVA, R.I. (2022)
TARGETED THERAPY
Ленватиниб у пациентов с нерезектабельной гепатоцеллюлярной карциномой в реальной клинической практике
Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
Петкау, В.В., Султанбаев, А.В., Меньшиков, К.В., Антипин, А.С., Волконский, М.В., Филиппова, В.М., Васильева, Ю.В., Тарханов, А.А., Мухитова, М.Р., Мурзалина, М.Ж., Сафарова, А.Р., Petkau, V.V., Sultanbaev, A.V., Menshikov, K.V., Antipin, A.S, Volkonsky, M.V., Filippova, V.M., Vasilyeva, Yu.V., Tarkhanov, A.A., Mukhitova, M.R., Murzalina, M.Zh., Safarova, A.R. (2022)
Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders
Dobrodeeva, V.S., Shnayder, N.A., Novitsky, M.A., Asadullin, A.R., Vaiman, E.E., Petrova, M.M., Limankin, O.V., Neznanov, N.G., Garganeeva, N.P., Nasyrova, R.F. (2022)
in the treatment of schizophrenia spectrum disorders (SSDs). The efficiency of APs is based on a range of target

Страница 1 из 13

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год